447 related articles for article (PubMed ID: 33624948)
21. Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.
Habiel DM; Hogaboam CM
Curr Pathobiol Rep; 2017 Jun; 5(2):101-110. PubMed ID: 29082111
[TBL] [Abstract][Full Text] [Related]
22. The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases.
Usman K; Hsieh A; Hackett TL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359876
[TBL] [Abstract][Full Text] [Related]
23. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K
Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
25. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
26. New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis.
Wang ZN; Tang XX
Front Cell Dev Biol; 2020; 8():580026. PubMed ID: 33117807
[TBL] [Abstract][Full Text] [Related]
27. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
28. 3D in vitro hydrogel models to study the human lung extracellular matrix and fibroblast function.
Phogat S; Thiam F; Al Yazeedi S; Abokor FA; Osei ET
Respir Res; 2023 Oct; 24(1):242. PubMed ID: 37798767
[TBL] [Abstract][Full Text] [Related]
29. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
Varma S; Mahavadi P; Sasikumar S; Cushing L; Hyland T; Rosser AE; Riccardi D; Lu J; Kalin TV; Kalinichenko VV; Guenther A; Ramirez MI; Pardo A; Selman M; Warburton D
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L405-19. PubMed ID: 24375798
[TBL] [Abstract][Full Text] [Related]
30. Cytokine signaling converging on
Kastlmeier MT; Gonzalez-Rodriguez E; Cabanis P; Guenther EM; König AC; Han L; Hauck SM; See F; Asgharpour S; Bukas C; Burgstaller G; Piraud M; Lehmann M; Hatz RA; Behr J; Stoeger T; Hilgendorff A; Voss C
Front Immunol; 2023; 14():1128239. PubMed ID: 37266432
[TBL] [Abstract][Full Text] [Related]
31. Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis.
Parimon T; Yao C; Stripp BR; Noble PW; Chen P
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32218238
[No Abstract] [Full Text] [Related]
32. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis.
Ligresti G; Raslan AA; Hong J; Caporarello N; Confalonieri M; Huang SK
Gene; 2023 Apr; 859():147142. PubMed ID: 36603696
[TBL] [Abstract][Full Text] [Related]
33. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; Pardo A
Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary lipofibroblasts in adults and alveolar regeneration in emphysema].
Justeau G; Toigo M; Castro de Freitas T; Ribeiro Baptista B; Zana-Taieb E; Boyer L
Rev Mal Respir; 2024 Apr; 41(4):299-302. PubMed ID: 38461092
[TBL] [Abstract][Full Text] [Related]
36. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
37. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
[TBL] [Abstract][Full Text] [Related]
38. Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases.
Cortesi EE; Meeusen B; Vanstapel A; Verleden SE; Vanaudenaerde BM; Wuyts WA; Janssens W; Janssens V; Roskams T; Ventura JJ
Cells; 2021 Dec; 10(12):. PubMed ID: 34943945
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regeneration.
Horiguchi M; Oiso Y; Sakai H; Motomura T; Yamashita C
J Control Release; 2015 Sep; 213():112-119. PubMed ID: 26160307
[TBL] [Abstract][Full Text] [Related]
40. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Wollin L; Wex E; Pautsch A; Schnapp G; Hostettler KE; Stowasser S; Kolb M
Eur Respir J; 2015 May; 45(5):1434-45. PubMed ID: 25745043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
